Search Results 2311-2320 of 20201 for Receptor

  1. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

    ... receptor. * Received prior systemic anticancer therapy including investigational agents within 4 weeks before randomization. * Received a live or live ...

  2. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

    * Has confirmation that either epidermal growth factor receptor (EGFR)-directed or anaplastic lymphoma kinase (ALK)-directed therapy is not indicated as ...

  3. Research of Experimental COVID-19 Therapeutics Explained - Mayo Clinic News Network

    The monoclonal antibody drugs block the receptor for interleukin 6, thereby preventing it from reaching cells. However, both drugs failed to show benefit ...

  4. A Study To Evaluate The Effectiveness And Safety Of Vibegron Administered Orally For 12 Weeks To Women With Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  5. Publications - Neal Niu, Ph.D. - Mayo Clinic

    Epub 2018 Nov 22. View PubMed; Madigan NN, Tracy JA, Litchy WJ, Niu Z, Chen C, Ling K, Milone M. A tropomyosin-receptor kinase-fused gene mutation associates ...

  6. Hematology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  7. Focal segmental glomerulosclerosis (FSGS) - Diagnosis and treatment - Mayo Clinic

    An angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB). These can lower blood pressure and reduce protein in the urine ...

  8. Publications - Chris D. Scott, M.D. - Mayo Clinic

    The angiotensin II type 2 receptor and improved adjacent region function post-MI. J Cardiovasc Magn Reson. 2005; 7 (2):459-64. View PubMed. PST-20583811. Home ...

  9. Childhood Obesity Clinical Trials - Mayo Clinic Research

    ... receptor in the melanocortin-leptin pathway. Since continued assessments of the safety and efficacy of setmelanotide are the same in this extension protocol ...

  10. Bone Cancer Clinical Trials - Mayo Clinic Research

    In this study, the SoC is defined as a combination of Androgen Receptor Directed Therapy + Androgen Deprivation Therapy. Pre-myeloid Cancer and Bone Marrow ...